A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo. J of Skin. 2017;1(3.1):s103. doi:10.25251/skin.1.supp.102